Clinical Guideline Alerts – June 2024
A list of clinical practice guidelines and guideline summaries that were updated or published in June 2024.
Read More
InSights Hub
News
Showing 161 to 170 of 283
(Page 17)
Upcoming FDA Decisions – July 2024
The Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug applications. Occasionally, an advisory committee (AdCom) meeting is convened to assess the drug […]
Read More
SITC May 2024 Guidelines Updates for Melanoma & Gynecologic Cancer – Guidelines Spotlight
The Society for Immunotherapy of Cancer (SITC) recently released focused updates to two of its clinical practice guidelines. This edition of our Guidelines Spotlight series will examine the key changes that you need to be aware of. Immunotherapy for the Treatment of Gynecologic Cancer Version 1.1 – Updated on May 24, 2024 Guideline Update Comments: […]
Read More
A Comparative Analysis of Migraine & Headache Management Guidelines – National Migraine & Headache Awareness Month
National Migraine and Headache Awareness Month, observed in June, is an annual event that highlights the importance of utilizing evidence-based strategies when crafting patient-centered treatment plans for individuals grappling with headaches and migraines. With headaches ranking the 5th most common reason for emergency department visits, it is no surprise that the CDC estimates migraine disorder […]
Read More
ISTH 2024 Conference Recap – Venous Thromboembolism (VTE)
The International Society on Thrombosis and Haemostasis held its annual conference (ISTH 2024) in Bangkok, Thailand from June 22-26th. It is the premier global organization dedicated to advancing the understanding, prevention, diagnosis, and treatment of conditions related to thrombosis and hemostasis. During ISTH 2024, groundbreaking research on venous thromboembolism (VTE) was presented, showcasing the latest […]
Read More
Imfinzi® Muscle-Invasive Bladder Cancer Trial Results NIAGARA – Guidelines+ Trials Spotlight
According to the American Cancer Society, bladder cancer accounts for approximately 4% of all cancers in the United States, making it the fourth most common cancer in men and less common in women. The likelihood of men developing bladder cancer in their lifetime is about 1 in 28, while for women, the chance is about […]
Read More
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After in Utero Exposure to Antiseizure Medication – Guidelines Spotlight
A focused guideline update “Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After in Utero Exposure to Antiseizure Medication” was released by the American Academy of Neurology (AAN), the American Epilepsy Society (AES), and the Society for Maternal-Fetal Medicine (SMFM) on May 15, 2024. The new guideline updates the previous 2009 guideline for “Management Issues for Women with […]
Read More
VAM24 Conference Recap – The Latest Research on Aortic Disease
The 2024 Vascular Annual Meeting (VAM24) took place from June 19-22 in Chicago, Illinois, serving as the Society of Vascular Surgery’s (SVS) premier event. This meeting provided a plethora of valuable scientific content tailored to meet the needs of every member of the vascular care team. A key focus of VAM24 was aortic disease, encompassing […]
Read More
Eosinophilic Esophagitis Guidelines – What’s Changed Since+ Guidelines Prediction Series
EoE (eosinophilic esophagitis) is a chronic, immune-mediated condition characterized by mucosal inflammation and esophageal dysfunction as the result of an eosinophilic-predominant immunogenic reaction. EoE, with onset typically secondary to genetic predisposition or antigen-triggered in etiology, results in damage to the esophagus that symptomatically can present as dysphagia, odynophagia, episodes of choking episodes, or can be […]
Read More
Survivorship Care for People Affected by Advanced or Metastatic Cancer – Guideline Spotlight
The Multinational Association for Supportive Care in Cancer and the American Society of Clinical Oncology (MASCC-ASCO) have recently published new guidelines entitled “Survivorship Care for Individuals Affected by Advanced or Metastatic Cancer,” on April 29, 2024. These guidelines provide comprehensive and evidence-based recommendations intended to improve the quality of life and optimize the outcomes for […]
Read More